Although our present study focuses on SPINK1-mediated tumor plasticity as one potential mechanism contributing to the functional enrichment of CD133+ cells following chemotherapy, other mechanisms, including survival signaling pathways and the TME, may also play significant roles. The gene discussed is SPINK1; the disease is neoplasm.